Theoretical framework for retrospective studies of the effectiveness of SARS-CoV-2 vaccines
Preprint
- 22 January 2021
- preprint
- research article
- Published by Cold Spring Harbor Laboratory
Abstract
Observational studies of the effectiveness of vaccines to prevent COVID-19 are needed to inform real-world use. These are now in planning amid the ongoing rollout of SARS-CoV-2 vaccines globally. While traditional case-control (TCC) and test-negative design (TND) studies feature prominently among strategies used to assess vaccine effectiveness, such studies may encounter important threats to validity. Here we review the theoretical basis for estimation of vaccine direct effects under TCC and TND frameworks, addressing specific natural history parameters of SARS-CoV-2 infection and COVID-19 relevant to these designs. Bias may be introduced by misclassification of cases and controls, particularly when clinical case criteria include common, non-specific indicators of COVID-19. When using diagnostic assays with high analytical sensitivity for SARS-CoV-2 detection, individuals testing positive may be counted as cases even if their symptoms are due to other causes. The TCC may be particularly prone to confounding due to associations of vaccination with healthcare-seeking behavior or risk of infection. The TND reduces but may not eliminate this confounding, for instance if individuals who receive vaccination seek care or testing for less-severe infection. These circumstances indicate the two study designs cannot be applied naively to datasets gathered through public health surveillance or administrative sources. We suggest practical strategies to reduce bias in vaccine effectiveness estimates at the study design and analysis stages.Keywords
Other Versions
- Published version: Version Epidemiology, 32, preprints
This publication has 44 references indexed in Scilit:
- Efficacy and Safety of the mRNA-1273 SARS-CoV-2 VaccineThe New England Journal of Medicine, 2021
- Safety and Efficacy of the BNT162b2 mRNA Covid-19 VaccineThe New England Journal of Medicine, 2020
- Postlicensure Evaluation of COVID-19 VaccinesJAMA, 2020
- What defines an efficacious COVID-19 vaccine? A review of the challenges assessing the clinical efficacy of vaccines against SARS-CoV-2The Lancet Infectious Diseases, 2020
- Uses of pathogen detection data to estimate vaccine direct effects in case–control studiesJournal of The Royal Society Interface, 2020
- The Use of Test-negative Controls to Monitor Vaccine EffectivenessEpidemiology, 2020
- Vaccine effects and impact of vaccination programmes in post-licensure studiesVaccine, 2013
- Design and Interpretation of Vaccine Field StudiesEpidemiologic Reviews, 1999
- Selection of Controls in Case-Control Studies: II. Types of ControlsAmerican Journal of Epidemiology, 1992
- Assessment of the Protective Efficacy of Vaccines against Common Diseases Using Case-Control and Cohort StudiesInternational Journal of Epidemiology, 1984